FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ross Baldessarini

Research Profile

Disorders

Living Beings

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Ross J Baldessarini; Gianni Faedda; Ciro Marangoni; Emanuela Offidani; Giulia Serra; Gustavo H Vázquez; Leonardo Tondo
Antidepressant-associated mood-switching and transition from unipolar major depression to bipolar disorder: A review.
Na Ye; Ross J Baldessarini; John L Neumeyer; Xuechu Zhen; Ao Zhang
Update 1 of: Recent Progress in Development of Dopamine Receptor Subtype-Selective Agents: Potential Therapeutics for Neurological and Psychiatric Disorders.
Tobias Pagel; Ross J Baldessarini; Jeremy Franklin; Christopher Baethge
Characteristics of patients diagnosed with schizoaffective disorder compared with schizophrenia and bipolar disorder.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ross Baldessarini (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ross J Baldessarini; Gianni Faedda; Ciro Marangoni; Emanuela Offidani; Giulia Serra; Gustavo H Vázquez; Leonardo Tondo
Antidepressant-associated mood-switching and transition from unipolar major depression to bipolar disorder: A review.
Journal of affective disorders 2013;148(1):129-35.
2013: Na Ye; Ross J Baldessarini; John L Neumeyer; Xuechu Zhen; Ao Zhang
Update 1 of: Recent Progress in Development of Dopamine Receptor Subtype-Selective Agents: Potential Therapeutics for Neurological and Psychiatric Disorders.
Chemical reviews 2013;113(5):PR123-78.
2013: Tobias Pagel; Ross J Baldessarini; Jeremy Franklin; Christopher Baethge
Characteristics of patients diagnosed with schizoaffective disorder compared with schizophrenia and bipolar disorder.
Bipolar disorders 2013;15(3):229-39.
2013: Juan Undurraga; Eduard Vieta; Stein Schalkwijk; Leonardo Tondo; Ross J Baldessarini
Re-analysis of the earliest controlled trials of imipramine.
Journal of affective disorders 2013;147(1-3):451-4.
2013: Leonardo Tondo; G Vázquez; Ross J Baldessarini; B Lepri; C Visioli
Clinical responses to antidepressants among 1036 acutely depressed patients with bipolar or unipolar major affective disorders.
Acta psychiatrica Scandinavica 2013;127(5):355-64.
2013: Chin Siang Lim; Ross J Baldessarini; Emre Bora; Eduard Vieta; Murat Yucel; Kang Sim
Longitudinal neuroimaging and neuropsychological changes in bipolar disorder patients: review of the evidence.
Neuroscience and biobehavioral reviews 2013;37(3):418-35.
2013: Jesús Pérez; Ross J Baldessarini; Fernando Girón-Irueste; Manuel Gurpegui; Jose de Leon
The lions of Granada Maristan.
The American journal of psychiatry 2013;170(2):152-3.
2013: Christopher Baethge; Oliver P Assall; Ross J Baldessarini
Systematic review of blinding assessment in randomized controlled trials in schizophrenia and affective disorders 2000-2010.
Psychotherapy and psychosomatics 2013;82(3):152-60.
2013: Emanuela Offidani; Elena Tomba; Giovanni A Fava; Ross J Baldessarini
Excessive mood elevation and behavioral activation with antidepressant treatment of juvenile depressive and anxiety disorders: a systematic review.
Psychotherapy and psychosomatics 2013;82(3):132-41.
2012: Paola Salvatore; Premananda Indic; Greg Murray; Ross J Baldessarini
Biological rhythms and mood disorders.
Dialogues in clinical neuroscience 2012;14(4):369-79.
2012: Ross J Baldessarini
Comparing tolerability of olanzapine in schizophrenia and affective disorders: a meta-analysis.
Drug safety : an international journal of medical toxicology and drug experience 2012;35(12):1183; author reply 1183-4.
2012: Jesús Pérez; Ross J Baldessarini; Juan Undurraga; José Sánchez-Moreno
Origins of psychiatric hospitalization in medieval Spain.
The Psychiatric quarterly 2012;83(4):419-30.
2012: Franca Centorrino; Grace A Masters; Alessandra Talamo; Ross J Baldessarini; Dost Ongür
Metabolic syndrome in psychiatrically hospitalized patients treated with antipsychotics and other psychotropics.
Human psychopharmacology 2012;27(5):521-6.
2012: Shi Hui Poon; Kang Sim; Min Yi Sum; Carissa Nadia Kuswanto; Ross J Baldessarini
Evidence-based options for treatment-resistant adult bipolar disorder patients.
Bipolar disorders 2012;14(6):573-84.
2012: Laura S Lorenzo; Leonardo Tondo; Gustavo H Vázquez; Rodolfo M Zaratiegui; Ross J Baldessarini
Characteristics of bipolar disorder patients given antidepressants.
Human psychopharmacology 2012;27(5):486-91.
2012: Juan Undurraga; Marc Valentí; Gustavo Vázquez; Ross J Baldessarini; Isabella Pacchiarotti; leonardo tondo; Eduard Vieta
Bipolar depression: clinical correlates of receiving antidepressants.
Journal of affective disorders 2012;139(1):89-93.
2012: Juan Undurraga; Marc Valenti; Ross J Baldessarini; Isabella Pacchiarotti; Eduard Vieta
Suicidal risk factors in bipolar I and II disorder patients.
The Journal of clinical psychiatry 2012;73(6):778-82.
2012: James Patrick Kelleher; John A Bates; Franca Centorrino; Jennifer Kidwell Drake; Samy Egli; Nancy A Huxley; Ross J Baldessarini
Pilot randomized, controlled trial of pramipexole to augment antipsychotic treatment.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2012;22(6):415-8.
2012: Ross J Baldessarini; J S Chang; K Ha; T H Ha; H-M K Khalsa; B Lepri; P Salvatore; M Tohen; Leonardo Tondo; J Undurraga; G H Vázquez; Eduard Vieta
Predominant recurrence polarity among 928 adult international bipolar I disorder patients.
Acta psychiatrica Scandinavica 2012;125(4):293-302.
2012: Juan Undurraga; Ross J Baldessarini
Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2012;37(4):851-64.
2012: Ross J Baldessarini; Lorenza Bolzani; Gianni L Faedda; Hari-Mandir K Khalsa; Massimo Lai; Beatrice Lepri; Maria Lolich; Pier Mario Maffei; Paola Salvatore; Leonardo Tondo; Juan Undurraga; Gustavo H Vazquez; Eduard Vieta; Aysegul Yildiz; Mauricio Tohen
Age at onset versus family history and clinical outcomes in 1,665 international bipolar-I disorder patients.
World psychiatry : official journal of the World Psychiatric Association (WPA) 2012;11(1):40-6.
2012: D Jeffrey Newport; Adele C Viguera; Ross J Baldessarini; Susana V Fernandez; Bettina T Knight; Natalie J Morris; Zachary N Stowe
Comparison of women with confirmed versus presumably misdiagnosed bipolar disorder.
The Journal of clinical psychiatry 2012;73(2):242-6.
2012: Eduardo A Leiderman; Maria Lolich; Gustavo H Vázquez; Ross J Baldessarini
Depression: point-prevalence and sociodemographic correlates in a Buenos Aires community sample.
Journal of affective disorders 2012;136(3):1154-8.
2012: Premananda Indic; Carlo Maggini; Tiziana Meschi; Greg Murray; Mario Amore; Ross J Baldessarini; Loris Borghi; Paola Salvatore
Multi-scale motility amplitude associated with suicidal thoughts in major depression.
PloS one 2012;7(6):e38761.
2012: Ross J Baldessarini; A Gonzalez-Pinto; H Imaz-Etxeberria; Hari-Mandir Kaur Khalsa; Paola Salvatore; Mauricio Tohen
Episode cycles with increasing recurrences in first-episode bipolar-I disorder patients.
Journal of affective disorders 2012;136(1-2):149-54.
2012: Mauricio Tohen; Eduard Vieta; Hari-Mandir Kaur Khalsa; Caitlin Ravichandran; Paola Salvatore; Ross J Baldessarini
Two-year outcomes in first-episode psychotic depression the McLean-Harvard First-Episode Project.
Journal of affective disorders 2012;136(1-2):1-8.
2011: Kang Sim; Chay Hoon Tan; Phern-Chern Tor; Jitendra Trivedi; Pichet Udomratn; Gabor S Ungvari; Chuan-Yue Wang; Yu-Tao Xiang; Shu-Yu Yang; Kian Hui Yong; Yiong Huak Chan; Kok Yoon Chee; Mian-Yoon Chong; Eun Kee Chung; Senta Fujii; Yan Ling He; Ee-Heok Kua; Edwin Ho Ming Lee; Norman Sartorius; Naotaka Shinfuku; Tianmei Si; Ross J Baldessarini
Adjunctive mood stabilizer treatment for hospitalized schizophrenia patients: Asia psychotropic prescription study (2001-2008).
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2011;14(9):1157-64.
2011: Maurizio Pompili; Danuta Wasserman; David Lester; Ross J Baldessarini; Alan L Berman; Diego De Leo; Paolo Girardi
Integration of suicidology with general medicine: an obligation to society.
Patient education and counseling 2011;85(1):127-8.
2011: Gustavo Vázquez; Ayşegül Yildiz; Ross J Baldessarini; Jorge M Tamayo; Leonardo Tondo; Paola Salvatore
Multisite international collaborative clinical trials in mania.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2011;14(8):1013-6.
2011: Ayşegül Yildiz; Mauricio Tohen; Eduard Vieta; Ross J Baldessarini
Factors modifying drug and placebo responses in randomized trials for bipolar mania.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2011;14(7):863-75.
2011: Phern-Chern Tor; Jintendra Trivedi; Pichet Udomratn; Gabor S Ungvari; Chuan-Yue Wang; Yu-Tao Xiang; Shu-Yu Yang; Kian-Hui Yong; Kok-Yoon Chee; Mian-Yoon Chong; Eun Kee Chung; Senta Fujii; Yan Ling He; Ee-Heok Kua; Edwin Ho Ming Lee; Tze Pin Ng; Norman Sartorius; Naotaka Shinfuku; Tianmei Si; Kang Sim; Chay Hoon Tan; Ross J Baldessarini
Adjunctive benzodiazepine treatment of hospitalized schizophrenia patients in Asia from 2001 to 2008.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2011;14(6):735-45.
2011: Ross J Baldessarini; David M Gardner
Incidence of extrapyramidal syndromes and tardive dyskinesia.
Journal of clinical psychopharmacology 2011;31(3):382-4; author reply 384-5.
2011: Ross J Baldessarini
Suicidal risk during antidepressant treatment.
The Journal of clinical psychiatry 2011;72(5):722; author reply 722.
2011: leonardo tondo; B Lepri; Ross J Baldessarini
Reproduction among 1975 Sardinian women and men diagnosed with major mood disorders.
Acta psychiatrica Scandinavica 2011;123(4):283-9.
2011: Jesús Pérez; Ross J Baldessarini; Núria Cruz; Paola Salvatore; Eduard Vieta
Andrés Piquer-Arrufat (1711-1772): contributions of an eighteenth-century spanish physician to the concept of manic-depressive illness.
Harvard review of psychiatry 2011;19(2):68-77.
2011: Antonio Ventriglio; Alessio Vincenti; Franca Centorrino; Alessandra Talamo; Garrett Fitzmaurice; Ross J Baldessarini
Use of mood stabilizers for hospitalized psychotic and bipolar disorder patients.
International clinical psychopharmacology 2011;26(2):88-95.
2011: Paola Salvatore; Ross J Baldessarini; Mauricio Tohen; Hari-Mandir K Khalsa; Jesus Perez Sanchez-Toledo; Carlos A Zarate; Eduard Vieta; Carlo Maggini
McLean-Harvard International First-Episode Project: two-year stability of ICD-10 diagnoses in 500 first-episode psychotic disorder patients.
The Journal of clinical psychiatry 2011;72(2):183-93.
2011: Premananda Indic; Carlo Maggini; Ross J Baldessarini; Gabriella Ferraro; Stefano Ghidini; Paola Salvatore; Greg Murray
Scaling behavior of human locomotor activity amplitude: association with bipolar disorder.
PloS one 2011;6(5):e20650.
2011: Daniel Tarsy; Codrin Lungu; Ross J Baldessarini
Epidemiology of tardive dyskinesia before and during the era of modern antipsychotic drugs.
Handbook of clinical neurology 2011;100():601-16.
2011: Ross J Baldessarini; Gustavo Vázquez; Leonardo Tondo
Treatment of cyclothymic disorder: commentary.
Psychotherapy and psychosomatics 2011;80(3):131-5.
2011: Ayşegül Yildiz; Eduard Vieta; Stefan Leucht; Ross J Baldessarini
Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2011;36(2):375-89.
2010: Maurizio Pompili; Ross J Baldessarini
Epilepsy: Risk of suicidal behavior with antiepileptic drugs.
Nature reviews. Neurology 2010;6(12):651-3.
2010: Ross J Baldessarini
Commentary: the Bipolar Affective Disorder: Lithium/Anticonvulsant Evaluation (BALANCE) study.
Bipolar disorders 2010;12(7):669-72.
2010: Ross J Baldessarini; Paola Salvatore; Hari-Mandir Kaur Khalsa; Mauricio Tohen
Dissimilar morbidity following initial mania versus mixed-states in type-I bipolar disorder.
Journal of affective disorders 2010;126(1-2):299-302.
2010: Ross J Baldessarini; leonardo tondo; Carmen Ghiani; Beatrice Lepri
Illness risk following rapid versus gradual discontinuation of antidepressants.
The American journal of psychiatry 2010;167(8):934-41.
2010: Ross J Baldessarini; Adele C Viguera
Perinatal screening for depression.
American journal of obstetrics and gynecology 2010;203(2):e16; author reply e17.
2010: Philip D Harvey; Aliza P Wingo; Katherine Burdick; Ross J Baldessarini
Cognition and disability in bipolar disorder: lessons from schizophrenia research.
Bipolar disorders 2010;12(4):364-75.
2010: David M Gardner; Andrea L Murphy; Heather O'Donnell; Franca Centorrino; Ross J Baldessarini
International consensus study of antipsychotic dosing.
The American journal of psychiatry 2010;167(6):686-93.
2010: Leonardo Tondo; B Lepri; N Cruz; Ross J Baldessarini
Age at onset in 3014 Sardinian bipolar and major depressive disorder patients.
Acta psychiatrica Scandinavica 2010;121(6):446-52.
2010: Leonardo Tondo; G Vázquez; Ross J Baldessarini
Mania associated with antidepressant treatment: comprehensive meta-analytic review.
Acta psychiatrica Scandinavica 2010;121(6):404-14.
2010: Aliza P Wingo; Ross J Baldessarini; Michael T Compton; Philip D Harvey
Correlates of recovery of social functioning in types I and II bipolar disorder patients.
Psychiatry research 2010;177(1-2):131-4.
2010: Aliza P Wingo; Ross J Baldessarini; Paul E Holtzheimer; Philip D Harvey
Factors associated with functional recovery in bipolar disorder patients.
Bipolar disorders 2010;12(3):319-26.
2010: Ross J Baldessarini; Paola Salvatore; Hari-Mandir Kaur Khalsa; Priscilla Gebre-Medhin; Harkaitz Imaz; Ana González-Pinto; Jesus Perez; Núria Cruz; Carlo Maggini; Mauricio Tohen
Morbidity in 303 first-episode bipolar I disorder patients.
Bipolar disorders 2010;12(3):264-70.
2010: Maurizio Pompili; Roberto Tatarelli; Paolo Girardi; Leonardo Tondo; Ross J Baldessarini
Suicide risk during anticonvulsant treatment.
Pharmacoepidemiology and drug safety 2010;19(5):525-8.
2010: Ross J Baldessarini; Eduard Vieta; Joseph Calabrese; Mauricio Tohen; Charles L Bowden
Bipolar depression: overview and commentary.
Harvard review of psychiatry 2010;18(3):143-57.
2010: Adele C Viguera; Lee S Cohen; Theodore Whitfield; Alison Reminick; Edward Bromfield; Ross J Baldessarini
Perinatal use of anticonvulsants: differences in attitudes and recommendations among neurologists and psychiatrists.
Archives of women's mental health 2010;13(2):175-8.
2010: Maurizio Pompili; Ross J Baldessarini; leonardo tondo; Marco Innamorati; Roberto Tatarelli; Paolo Girardi; Eleonora De Pisa
Response to intravenous antidepressant treatment by suicidal vs. nonsuicidal depressed patients.
Journal of affective disorders 2010;122(1-2):154-8.
2010: Franca Centorrino; Antonio Ventriglio; Alessio Vincenti; Alessandra Talamo; Ross J Baldessarini
Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004.
Human psychopharmacology 2010;25(2):179-86.
2010: P Girardi; Gianluca Serafini; M Pompili; Marco Innamorati; R Tatarelli; Ross J Baldessarini
Prospective, open study of long-acting injected risperidone versus oral antipsychotics in 88 chronically psychotic patients.
Pharmacopsychiatry 2010;43(2):66-72.
2010: Ross J Baldessarini; Leonardo Tondo; Beatrice Lepri
Correlation of initial wellness with long-term morbidity in recurrent major affective disorder patients as a test of survival analysis.
Journal of clinical psychopharmacology 2010;30(1):72-5.
2010: Ross J Baldessarini; L Bolzani; N Cruz; P B Jones; M Lai; B Lepri; J Perez; Paola Salvatore; Mauricio Tohen; leonardo tondo; Eduard Vieta
Onset-age of bipolar disorders at six international sites.
Journal of affective disorders 2010;121(1-2):143-6.
2009: Chaya G Bhuvaneswar; Ross J Baldessarini; Veronica L Harsh; Jonathan E Alpert
Adverse endocrine and metabolic effects of psychotropic drugs: selective clinical review.
CNS drugs 2009;23(12):1003-21.
2009: Eduard Vieta; Michael Berk; W Wang; F Colom; Mauricio Tohen; Ross J Baldessarini
Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patients.
Journal of affective disorders 2009;119(1-3):22-7.
2009: Aliza P Wingo; Thomas S Wingo; Philip D Harvey; Ross J Baldessarini
Effects of lithium on cognitive performance: a meta-analysis.
The Journal of clinical psychiatry 2009;70(11):1588-97.
2009: Jan A Fawcett; Ross J Baldessarini; William H Coryell; Morton M Silverman; Dan Stein
Definition and management of suicidality in psychiatric patients.
The Journal of clinical psychiatry 2009;70(10):e38.
2009: Christopher Baethge; Leonardo Tondo; Beatrice Lepri; Ross J Baldessarini
Coffee and cigarette use: association with suicidal acts in 352 Sardinian bipolar disorder patients.
Bipolar disorders 2009;11(5):494-503.
2009: Leonardo Tondo; Ross J Baldessarini
Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients.
Epidemiologia e psichiatria sociale 2009;18(3):179-83.
2009: Jan A Fawcett; Ross J Baldessarini; William H Coryell; Morton M Silverman; Dan Stein
Defining and managing suicidal risk in patients taking psychotropic medications.
The Journal of clinical psychiatry 2009;70(6):782-9.
2009: Ross J Baldessarini
Atypical antipsychotic drugs and the risk of sudden cardiac death.
The New England journal of medicine 2009;360(20):2136-7; author reply 2137-8.
2009: Paolo Girardi; Maurizio Pompili; Marco Innamorati; Michele Mancini; Gianluca Serafini; Lorenzo Mazzarini; Antonio Del Casale; Roberto Tatarelli; Ross J Baldessarini
Duloxetine in acute major depression: review of comparisons to placebo and standard antidepressants using dissimilar methods.
Human psychopharmacology 2009;24(3):177-90.
2009: Paola Salvatore; Ross J Baldessarini; Mauricio Tohen; Hari-Mandir K Khalsa; Jesus Perez Sanchez-Toledo; Carlos A Zarate; Eduard Vieta; Carlo Maggini
McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients.
The Journal of clinical psychiatry 2009;70(4):458-66.
2009: Ross J Baldessarini; L Tondo
Suicidal risks during treatment of bipolar disorder patients with lithium versus anticonvulsants.
Pharmacopsychiatry 2009;42(2):72-5.
2009: Aliza P Wingo; Philip D Harvey; Ross J Baldessarini
Neurocognitive impairment in bipolar disorder patients: functional implications.
Bipolar disorders 2009;11(2):113-25.
2009: Anne Gross; Matthew Altman; Paola Salvatore; Ross J Baldessarini; Marni Chanoff; Joseph P Powers
An atypical, chronic psychotic disorder in a 55-year-old man.
Harvard review of psychiatry 2009;17(5):329-43.
2009: Daniel V Vigo; Ross J Baldessarini
Anticonvulsants in the treatment of major depressive disorder: an overview.
Harvard review of psychiatry 2009;17(4):231-41.
2009: Katharina Trede; Ross J Baldessarini; Adele C Viguera; Alain Bottero
Treatise on insanity in pregnant, postpartum, and lactating women (1858) by Louis-Victor Marcé: a commentary.
Harvard review of psychiatry 2009;17(2):157-65.
2009: Yu-Gui Si; Yong-Kee Choi; Matthew P Gardner; Frank I Tarazi; Ross J Baldessarini; John L Neumeyer
Synthesis and neuropharmacological evaluation of esters of R(-)-N-alkyl-11-hydroxy-2-methoxynoraporphines.
Bioorganic & medicinal chemistry letters 2009;19(1):51-3.
2008: Ross J Baldessarini
Comments on article by Dr Birkenhager et al: "Efficacy of imipramine in psychotic versus nonpsychotic depression".
Journal of clinical psychopharmacology 2008;28(6):716; author reply 717-8.
2008: Ross J Baldessarini; Henry Henk; Ami Sklar; Jane Chang; Leslie Leahy
Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence.
Psychiatric services (Washington, D.C.) 2008;59(10):1175-83.
2008: Christopher Baethge; John Hennen; Hari-Mandir Kaur Khalsa; Paola Salvatore; Mauricio Tohen; Ross J Baldessarini
Sequencing of substance use and affective morbidity in 166 first-episode bipolar I disorder patients.
Bipolar disorders 2008;10(6):738-41.
2008: Alessandra Talamo; Ross J Baldessarini; Franca Centorrino
Comparison of mania patients suitable for treatment trials versus clinical treatment.
Human psychopharmacology 2008;23(6):447-54.
2008: Leonardo Tondo; B Lepri; Ross J Baldessarini
Suicidal status during antidepressant treatment in 789 Sardinian patients with major affective disorder.
Acta psychiatrica Scandinavica 2008;118(2):106-15.
2008: Yu-Gui Si; Matthew P Gardner; Frank I Tarazi; Ross J Baldessarini; John L Neumeyer
Synthesis and binding studies of 2-O- and 11-O-substituted N-alkylnoraporphines.
Bioorganic & medicinal chemistry letters 2008;18(14):3971-3.
2008: Evangelia M Tsapakis; Federico Soldani; leonardo tondo; Ross J Baldessarini
Efficacy of antidepressants in juvenile depression: meta-analysis.
The British journal of psychiatry : the journal of mental science 2008;193(1):10-7.
2008: D Jeffrey Newport; Zachary N Stowe; Adele C Viguera; Martha R Calamaras; Sandra Juric; Bettina Knight; Page B Pennell; Ross J Baldessarini
Lamotrigine in bipolar disorder: efficacy during pregnancy.
Bipolar disorders 2008;10(3):432-6.
2008: Paola Salvatore; Stefano Ghidini; Gianmaria Zita; Chiara De Panfilis; Samuele Lambertino; Carlo Maggini; Ross J Baldessarini
Circadian activity rhythm abnormalities in ill and recovered bipolar I disorder patients.
Bipolar disorders 2008;10(2):256-65.
2008: Ross J Baldessarini; Richard Perry; James Pike
Factors associated with treatment nonadherence among US bipolar disorder patients.
Human psychopharmacology 2008;23(2):95-105.
2008: Yu-Gui Si; Matthew P Gardner; Frank I Tarazi; Ross J Baldessarini; John L Neumeyer
Synthesis and dopamine receptor affinities of N-alkyl-11-hydroxy-2-methoxynoraporphines: N-alkyl substituents determine D1 versus D2 receptor selectivity.
Journal of medicinal chemistry 2008;51(4):983-7.
2008: Ross J Baldessarini; Leonardo Tondo
Lithium and suicidal risk.
Bipolar disorders 2008;10(1):114-5.
2008: Hari-Mandir Kaur Khalsa; Paola Salvatore; John Hennen; Christopher Baethge; Mauricio Tohen; Ross J Baldessarini
Suicidal events and accidents in 216 first-episode bipolar I disorder patients: predictive factors.
Journal of affective disorders 2008;106(1-2):179-84.
2008: Frances R Frankenburg; Ross J Baldessarini
Neurosyphilis, malaria, and the discovery of antipsychotic agents.
Harvard review of psychiatry 2008;16(5):299-307.
2008: Paola Salvatore; Chaya Bhuvaneswar; Daniel Ebert; Carlo Maggini; Ross J Baldessarini
Cycloid psychoses revisited: case reports, literature review, and commentary.
Harvard review of psychiatry 2008;16(3):167-80.
2008: Sherry A Nykiel; Ross J Baldessarini; Montgomery C Bower; Jean Goodwin; Paola Salvatore
Psychosis NOS: search for diagnostic clarity.
Harvard review of psychiatry 2008;16(1):55-65.
2008: Frederic Bois; Ronald M Baldwin; Louis Amici; Mohammed S Al-Tikriti; Nora S Kula; Ross J Baldessarini; Robert B Innis; Julie K Staley; Gilles Tamagnan
Synthesis, radiolabeling and baboon SPECT imaging of 2beta-carbomethoxy-3beta-(3'-[(123)I]iodophenyl)tropane ([(123)I]YP256) as a serotonin transporter radiotracer.
Nuclear medicine and biology 2008;35(1):53-9.
2008: Franca Centorrino; Stephanie L Cincotta; Alessandra Talamo; Kate V Fogarty; Francesca Guzzetta; Mark G Saadeh; Paola Salvatore; Ross J Baldessarini
Hospital use of antipsychotic drugs: polytherapy.
Comprehensive psychiatry 2008;49(1):65-9.
2007: Adele C Viguera; Theodore Whitfield; Ross J Baldessarini; D Jeffrey Newport; Zachary N Stowe; Alison Reminick; Amanda Zurick; Lee S Cohen
Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation.
The American journal of psychiatry 2007;164(12):1817-24; quiz 1923.
2007: Leonardo Tondo; B Lepri; Ross J Baldessarini
Suicidal risks among 2826 Sardinian major affective disorder patients.
Acta psychiatrica Scandinavica 2007;116(6):419-28.
2007: Paola Salvatore; Hari-Mandir Kaur Khalsa; John Hennen; Mauricio Tohen; Deborah Yurgelun-Todd; F Casolari; C Depanfilis; Carlo Maggini; Ross J Baldessarini
Psychopathology factors in first-episode affective and non-affective psychotic disorders.
Journal of psychiatric research 2007;41(9):724-36.
2007: Robert J Valuck; Anne M Libby; Heather D Orton; Elaine H Morrato; Richard Allen; Ross J Baldessarini
Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs.
The American journal of psychiatry 2007;164(8):1198-205.
2007: Helen H Kyomen; Theodore H Whitfield; Ross J Baldessarini
Levetiracetam for manic behavior in hospitalized geriatric patients with dementia of the Alzheimer's type.
Journal of clinical psychopharmacology 2007;27(4):408-10.
2007: Yu-Gui Si; Matthew P Gardner; Frank I Tarazi; Ross J Baldessarini; John L Neumeyer
R-(-)-N-alkyl-11-hydroxy-10-hydroxymethyl- and 10-methyl-aporphines as 5-HT1A receptor ligands.
Bioorganic & medicinal chemistry letters 2007;17(15):4128-30.
2007: Ross J Baldessarini; Leonardo Tondo; Indiana M Strombom; Svetlana Dominguez; Jan Fawcett; Julio Licinio; Maria A Oquendo; Gary D Tollefson; Robert J Valuck; Mauricio Tohen
Ecological studies of antidepressant treatment and suicidal risks.
Harvard review of psychiatry 2007;15(4):133-45.
2007: Ross J Baldessarini; Leonardo Tondo; Christopher Baethge; Beatrice Lepri; Irene M Bratti
Effects of treatment latency on response to maintenance treatment in manic-depressive disorders.
Bipolar disorders 2007;9(4):386-93.
2007: Taylor Moran-Gates; Christopher Grady; Young Shik Park; Ross J Baldessarini; Frank I Tarazi
Effects of risperidone on dopamine receptor subtypes in developing rat brain.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2007;17(6-7):448-55.
2007: Paola Salvatore; Mauricio Tohen; Hari-Mandir Kaur Khalsa; Christopher Baethge; Leonardo Tondo; Ross J Baldessarini
Longitudinal research on bipolar disorders.
Epidemiologia e psichiatria sociale 2007;16(2):109-17.
2007: Kang Sim; N B Lee; Hong Choon Chua; Rathi Mahendran; Senta Fujii; Shu-Yu Yang; Mian-Yoon Chong; Tianmei Si; Yan L He; Min S Lee; Kil M Sung; Eun Kee Chung; Yiong H Chan; Naotaka Shinfuku; Chay H Tan; Norman Sartorius; Ross J Baldessarini
Newer antidepressant drug use in East Asian psychiatric treatment settings: REAP (Research on East Asia Psychotropic Prescriptions) Study.
British journal of clinical pharmacology 2007;63(4):431-7.
2007: Francesca Guzzetta; Leonardo Tondo; Franca Centorrino; Ross J Baldessarini
Lithium treatment reduces suicide risk in recurrent major depressive disorder.
The Journal of clinical psychiatry 2007;68(3):380-3.
2007: Harry Pantazopoulos; Nicholas Lange; Ross J Baldessarini; Sabina Berretta
Parvalbumin neurons in the entorhinal cortex of subjects diagnosed with bipolar disorder or schizophrenia.
Biological psychiatry 2007;61(5):640-52.
2007: Nancy Huxley; Ross J Baldessarini
Disability and its treatment in bipolar disorder patients.
Bipolar disorders 2007;9(1-2):183-96.
2007: Adele C Viguera; D Jeffrey Newport; James Ritchie; Zachary N Stowe; Theodore Whitfield; Juliana Mogielnicki; Ross J Baldessarini; Amanda Zurick; Lee S Cohen
Lithium in breast milk and nursing infants: clinical implications.
The American journal of psychiatry 2007;164(2):342-5.
2007: Ao Zhang; Yi Zhang; Alan R Branfman; Ross J Baldessarini; John L Neumeyer
Advances in development of dopaminergic aporphinoids.
Journal of medicinal chemistry 2007;50(2):171-81.
2007: Gilles Tamagnan; Eric Brenner; David Alagille; Julie K Staley; Colin Haile; Andrei O KoreN; Michele Early; Ronald M Baldwin; Frank I Tarazi; Ross J Baldessarini; Nachwa Jarkas; Mark M Goodman; John P Seibyl
Development of SPECT imaging agents for the norepinephrine transporters: [123I]INER.
Bioorganic & medicinal chemistry letters 2007;17(2):533-7.
2007: Adele C Viguera; Alexia Koukopoulos; David J Muzina; Ross J Baldessarini
Teratogenicity and anticonvulsants: lessons from neurology to psychiatry.
The Journal of clinical psychiatry 2007;68 Suppl 9():29-33.
2007: S Nassir Ghaemi; Ross J Baldessarini
The manic-depressive spectrum and mood stabilization: Kraepelin's ghost.
Psychotherapy and psychosomatics 2007;76(2):65-9.
2007: Ross J Baldessarini; Leslie Leahy; Stephen Arcona; Douglas Gause; Winnie Zhang; John Hennen
Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders.
Psychiatric services (Washington, D.C.) 2007;58(1):85-91.
2007: Ao Zhang; John L Neumeyer; Ross J Baldessarini
Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders.
Chemical reviews 2007;107(1):274-302.
2006: Nayan Acharya; Amy S Rosen; John P Polzer; Deborah N D'Souza; David Perahia; Patrizia Cavazzoni; Ross J Baldessarini
Duloxetine: meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder.
Journal of clinical psychopharmacology 2006;26(6):587-94.
2006: Ross J Baldessarini; Leonardo Tondo; Paula Davis; Maurizio Pompili; Frederick K Goodwin; John Hennen
Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review.
Bipolar disorders 2006;8(5 Pt 2):625-39.
2006: Ana Gonzalez-Pinto; Fernando Mosquera; Marta Alonso; Purificación López; Fernando Ramírez; Eduard Vieta; Ross J Baldessarini
Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment.
Bipolar disorders 2006;8(5 Pt 2):618-24.
2006: Frederic Bois; Ronald M Baldwin; Nora S Kula; Ross J Baldessarini; Mohammed S Al-Tikriti; Robert B Innis; Gilles Tamagnan
Synthesis and monoamine transporter affinity of 2beta-carbomethoxy-3beta-(4'-p-substituted phenyl)-piperidine analogs of cocaine.
Bioorganic & medicinal chemistry letters 2006;16(19):5222-5.
2006: Alessandra Talamo; Franca Centorrino; Leonardo Tondo; A Dimitri; John Hennen; Ross J Baldessarini
Comorbid substance-use in schizophrenia: relation to positive and negative symptoms.
Schizophrenia research 2006;86(1-3):251-5.
2006: John P Houston; Jonna Ahl; Adam L Meyers; Christopher J Kaiser; Mauricio Tohen; Ross J Baldessarini
Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex.
The Journal of clinical psychiatry 2006;67(8):1246-52.
2006: Ross J Baldessarini; Maurizio Pompili; Leonardo Tondo
Suicide in bipolar disorder: Risks and management.
CNS spectrums 2006;11(6):465-71.
2006: Gian Paolo Minnai; Leonardo Tondo; Piergiorgio Salis; Carmen Ghiani; Andrea Manfredi; Michela M Paluello; Christopher Baethge; Ross J Baldessarini
Secular trends in first hospitalizations for major mood disorders with comorbid substance use.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2006;9(3):319-26.
2006: Daniel Tarsy; Ross J Baldessarini
Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics?
Movement disorders : official journal of the Movement Disorder Society 2006;21(5):589-98.
2006: Leonardo Tondo; Ross J Baldessarini
Strategies to prevent suicide.
JAMA : the journal of the American Medical Association 2006;295(13):1515; author reply 1516.
2006: Leonardo Tondo; Matthew J Albert; Ross J Baldessarini
Suicide rates in relation to health care access in the United States: an ecological study.
The Journal of clinical psychiatry 2006;67(4):517-23.
2006: Franca Centorrino; John Hennen; Gopinath Mallya; Samy Egli; Tim Clark; Ross J Baldessarini
Clinical outcome in patients with bipolar I disorder, obsessive compulsive disorder or both.
Human psychopharmacology 2006;21(3):189-93.
2006: Miklós Tóth; Sándor Berényi; Csaba Csutorás; Nora S Kula; Kehong Zhang; Ross J Baldessarini; John L Neumeyer
Synthesis and dopamine receptor binding of sulfur-containing aporphines.
Bioorganic & medicinal chemistry 2006;14(6):1918-23.
2006: Ross J Baldessarini; Maurizio Pompili; Leonardo Tondo
Suicidal risk in antidepressant drug trials.
Archives of general psychiatry 2006;63(3):246-8.
2006: J John Mann; Graham J Emslie; Ross J Baldessarini; William Beardslee; Jan A Fawcett; Frederick K Goodwin; Andrew C Leon; Herbert Y Meltzer; Neal D Ryan; David Shaffer; Karen D Wagner
ACNP Task Force report on SSRIs and suicidal behavior in youth.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(3):473-92.
2006: Taylor Moran-Gates; Lu Gan; Young Shik Park; Kehong Zhang; Ross J Baldessarini; Frank I Tarazi
Repeated antipsychotic drug exposure in developing rats: dopamine receptor effects.
Synapse (New York, N.Y.) 2006;59(2):92-100.
2006: Gilles Tamagnan; David Alagille; XINGZHENG FU; Nora S Kula; Ross J Baldessarini; Robert B Innis; Ronald M Baldwin
Synthesis and monoamine transporter affinity of new 2beta-carbomethoxy-3beta-[aryl or heteroaryl]phenyltropanes.
Bioorganic & medicinal chemistry letters 2006;16(1):217-20.
2005: Marni J Grant; Ross J Baldessarini
Possible improvement of neuroleptic-associated tardive dyskinesia during treatment with aripiprazole.
The Annals of pharmacotherapy 2005;39(11):1953.
2005: Franca Centorrino; Kate V Fogarty; Gabriele Sani; Paola Salvatore; Stephanie L Cincotta; John Hennen; Francesca Guzzetta; Alessandra Talamo; Mark G Saadeh; Ross J Baldessarini
Use of combinations of antipsychotics: McLean Hospital inpatients, 2002.
Human psychopharmacology 2005;20(7):485-92.
2005: Jennifer L Derenne; Ross J Baldessarini
Clozapine toxicity associated with smoking cessation: case report.
American journal of therapeutics 2005;12(5):469-71.
2005: Taylor Moran-Gates; Kehong Zhang; Ross J Baldessarini; Frank I Tarazi
Atomoxetine blocks motor hyperactivity in neonatal 6-hydroxydopamine-lesioned rats: implications for treatment of attention-deficit hyperactivity disorder.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2005;8(3):439-44.
2005: Robert A Lasser; Cynthia A Bossie; Georges Gharabawi; Ross J Baldessarini
Clinical improvement in 336 stable chronically psychotic patients changed from oral to long-acting risperidone: a 12-month open trial.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2005;8(3):427-38.
2005: Franca Centorrino; Kate V Fogarty; Paola Cimbolli; Paola Salvatore; Terri-Ann Thompson; Gabriele Sani; Stephanie L Cincotta; Ross J Baldessarini
Aripiprazole: initial clinical experience with 142 hospitalized psychiatric patients.
Journal of psychiatric practice 2005;11(4):241-7.
2005: Franca Centorrino; Kate V Fogarty; Gabriele Sani; Paola Salvatore; Paola Cimbolli; Ross J Baldessarini
Antipsychotic drug use: McLean Hospital, 2002.
Human psychopharmacology 2005;20(5):355-8.
2005: Federico Soldani; S Nassir Ghaemi; Ross J Baldessarini
Research reports on treatments for bipolar disorder: preliminary assessment of methodological quality.
Acta psychiatrica Scandinavica 2005;112(1):72-4.
2005: Federico Soldani; S Nassir Ghaemi; Ross J Baldessarini
Research methods in psychiatric treatment studies. Critique and proposals.
Acta psychiatrica Scandinavica 2005;112(1):1-3.
2005: David M Gardner; Ross J Baldessarini; Paul Waraich
Modern antipsychotic drugs: a critical overview.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2005;172(13):1703-11.
2005: Katharina Trede; Paola Salvatore; Christopher Baethge; Angela Gerhard; Carlo Maggini; Ross J Baldessarini
Manic-depressive illness: evolution in Kraepelin's Textbook, 1883-1926.
Harvard review of psychiatry 2005;13(3):155-78.
2005: Christopher Baethge; Ross J Baldessarini; Hari-Mandir Kaur Khalsa; John Hennen; Paola Salvatore; Mauricio Tohen
Substance abuse in first-episode bipolar I disorder: indications for early intervention.
The American journal of psychiatry 2005;162(5):1008-10.
2005: Christopher Baethge; Ross J Baldessarini; Klaus Freudenthal; Anna Streeruwitz; Michael Bauer; Tom Bschor
Hallucinations in bipolar disorder: characteristics and comparison to unipolar depression and schizophrenia.
Bipolar disorders 2005;7(2):136-45.
2005: Ross J Baldessarini; Gianni Faedda; John Hennen
Risk of mania with antidepressants.
Archives of pediatrics & adolescent medicine 2005;159(3):298; author reply 298-9.
2005: John Hennen; Ross J Baldessarini
Suicidal risk during treatment with clozapine: a meta-analysis.
Schizophrenia research 2005;73(2-3):139-45.
2005: Meng-Yang Zhu; Wei-Ping Wang; Ross J Baldessarini; Kwang-Soo Kim
Effects of desipramine treatment on tyrosine hydroxylase gene expression in cultured neuroblastoma cells and rat brain tissue.
Brain research. Molecular brain research 2005;133(2):167-75.
2005: Gilles Tamagnan; David Alagille; XINGZHENG FU; Nora S Kula; Ross J Baldessarini; Robert B Innis; Ronald M Baldwin
Synthesis and monoamine transporter affinity of new 2beta-carbomethoxy-3beta-[4-(substituted thiophenyl)]phenyltropanes: discovery of a selective SERT antagonist with picomolar potency.
Bioorganic & medicinal chemistry letters 2005;15(4):1131-3.
2005: Christopher Baethge; Ross J Baldessarini; Kirsten Mathiske-Schmidt; John Hennen; Anne Berghöfer; Bruno Müller-Oerlinghausen; Tom Bschor; Mazda Adli; Michael Bauer
Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients.
The Journal of clinical psychiatry 2005;66(2):174-82.
2005: K N Roy Chengappa; John Hennen; Ross J Baldessarini; David J Kupfer; Lakshmi N Yatham; Samuel Gershon; Robert W Baker; Mauricio Tohen
Recovery and functional outcomes following olanzapine treatment for bipolar I mania.
Bipolar disorders 2005;7(1):68-76.
2004: John Hennen; Roy H Perlis; Gary Sachs; Mauricio Tohen; Ross J Baldessarini
Weight gain during treatment of bipolar I patients with olanzapine.
The Journal of clinical psychiatry 2004;65(12):1679-87.
2004: Xuemei Peng; Ao Zhang; Nora S Kula; Ross J Baldessarini; John L Neumeyer
Synthesis and amine transporter affinities of novel phenyltropane derivatives as potential positron emission tomography (PET) imaging agents.
Bioorganic & medicinal chemistry letters 2004;14(22):5635-9.
2004: Franca Centorrino; Elizabeth MacLean; Paola Salvatore; Jennifer E Kidwell; Kate V Fogarty; Judith M Berry; Ross J Baldessarini
Ziprasidone: first year experience in a hospital setting.
Journal of psychiatric practice 2004;10(6):361-7.
2004: Eduard Vieta; Joseph Calabrese; John Hennen; Francesc Colom; Anabel Martínez-Arán; José Sánchez-Moreno; Lakshmi N Yatham; Mauricio Tohen; Ross J Baldessarini
Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data.
The Journal of clinical psychiatry 2004;65(10):1420-8.
2004: Gianni Faedda; Ross J Baldessarini; Ira P Glovinsky; Nancy B Austin
Treatment-emergent mania in pediatric bipolar disorder: a retrospective case review.
Journal of affective disorders 2004;82(1):149-58.
2004: Kehong Zhang; Christopher J Grady; Evangelia M Tsapakis; Susan L Andersen; Frank I Tarazi; Ross J Baldessarini
Regulation of working memory by dopamine D4 receptor in rats.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(9):1648-55.
2004: Frank I Tarazi; Kehong Zhang; Ross J Baldessarini
Dopamine D4 receptors: beyond schizophrenia.
Journal of receptor and signal transduction research 2004;24(3):131-47.
2004: Gianni Faedda; Ross J Baldessarini; Ira P Glovinsky; Nancy B Austin
Pediatric bipolar disorder: phenomenology and course of illness.
Bipolar disorders 2004;6(4):305-13.
2004: Csaba Csutoras; Ao Zhang; Kehong Zhang; Nora S Kula; Ross J Baldessarini; John L Neumeyer
Synthesis and neuropharmacological evaluation of R(-)-N-alkyl-11-hydroxynoraporphines and their esters.
Bioorganic & medicinal chemistry 2004;12(13):3553-9.
2004: Christopher Baethge; Ira Glovinsky; Ross J Baldessarini
Manic-depressive illness in children: an early twentieth-century view by Theodor Ziehen (1862-1950). Introduction.
History of psychiatry 2004;15(58 Pt 2):201-26.
2004: Frederic Bois; Ronald M Baldwin; Nora S Kula; Ross J Baldessarini; Robert B Innis; Gilles Tamagnan
Synthesis and monoamine transporter affinity of 3'-analogs of 2-beta-carbomethoxy-3-beta-(4'-iodophenyl)tropane (beta-CIT).
Bioorganic & medicinal chemistry letters 2004;14(9):2117-20.
2004: Franca Centorrino; Jessica Goren; John Hennen; Paola Salvatore; James Patrick Kelleher; Ross J Baldessarini
Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits.
The American journal of psychiatry 2004;161(4):700-6.
2004: Lu Gan; Tomas L Falzone; Kehong Zhang; Marcelo Rubinstein; Ross J Baldessarini; Frank I Tarazi
Enhanced expression of dopamine D(1) and glutamate NMDA receptors in dopamine D(4) receptor knockout mice.
Journal of molecular neuroscience : MN 2004;22(3):167-78.
2004: Ross J Baldessarini; John Hennen
Genetics of suicide: an overview.
Harvard review of psychiatry 2004;12(1):1-13.
2004: S Nassir Ghaemi; Klara J Rosenquist; James Y Ko; Claudia F Baldassano; Nicholas Kontos; Ross J Baldessarini
Antidepressant treatment in bipolar versus unipolar depression.
The American journal of psychiatry 2004;161(1):163-5.
2004: Godehard Oepen; Ross J Baldessarini; Paola Salvatore; Eliot Slater
On the periodicity of manic-depressive insanity, by Eliot Slater (1938): translated excerpts and commentary.
Journal of affective disorders 2004;78(1):1-9.
2003: Mauricio Tohen; Carlos A Zarate; John Hennen; Hari-Mandir Kaur Khalsa; Stephen M Strakowski; Priscilla Gebre-Medhin; Paola Salvatore; Ross J Baldessarini
The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence.
The American journal of psychiatry 2003;160(12):2099-107.
2003: Eugene V Beresin; Ross J Baldessarini; Jonathan Alpert; Jerrold Rosenbaum
Teaching ethics of psychopharmacology research in psychiatric residency training programs.
Psychopharmacology 2003;171(1):105-11.
2003: Ronald M Baldwin; XINGZHENG FU; Nora S Kula; Ross J Baldessarini; Louis Amici; Robert B Innis; Gilles Tamagnan
Synthesis and affinity of a possible byproduct of electrophilic radiolabeling of [123I]IBZM.
Bioorganic & medicinal chemistry letters 2003;13(22):4015-7.
2003: Franca Centorrino; Matthew J Albert; Judith M Berry; James Patrick Kelleher; Veronica Fellman; Gyorgy Line; Athanasios Koukopoulos; Jennifer E Kidwell; Kate V Fogarty; Ross J Baldessarini
Oxcarbazepine: clinical experience with hospitalized psychiatric patients.
Bipolar disorders 2003;5(5):370-4.
2003: Ross J Baldessarini; Leonardo Tondo
Suicide risk and treatments for patients with bipolar disorder.
JAMA : the journal of the American Medical Association 2003;290(11):1517-9.
2003: Herbert Y Meltzer; Ross J Baldessarini
Reducing the risk for suicide in schizophrenia and affective disorders.
The Journal of clinical psychiatry 2003;64(9):1122-9.
2003: Christopher Baethge; Paola Salvatore; Ross J Baldessarini
Cyclothymia, a circular mood disorder.
History of psychiatry 2003;14(55 Pt 3):377-99.
2003: Irene M Bratti; Ross J Baldessarini; Christopher Baethge; Leonardo Tondo
Pretreatment episode count and response to lithium treatment in manic-depressive illness.
Harvard review of psychiatry 2003;11(5):245-56.
2003: Frank I Tarazi; Ross J Baldessarini; Nora S Kula; Kehong Zhang
Long-term effects of olanzapine, risperidone, and quetiapine on ionotropic glutamate receptor types: implications for antipsychotic drug treatment.
The Journal of pharmacology and experimental therapeutics 2003;306(3):1145-51.
2003: John L Neumeyer; Nora S Kula; Jack Bergman; Ross J Baldessarini
Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines.
European journal of pharmacology 2003;474(2-3):137-40.
2003: Christopher Baethge; Leonardo Tondo; Irene M Bratti; Tom Bschor; Michael Bauer; Adele C Viguera; Ross J Baldessarini
Prophylaxis latency and outcome in bipolar disorders.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2003;48(7):449-57.
2003: Ross J Baldessarini; John Hennen; Michael Wilson; Joseph Calabrese; Roy Chengappa; Paul E Keck; Susan L McElroy; Gary Sachs; Eduard Vieta; Jeffrey Welge; Lakshmi N Yatham; Carlos A Zarate; Robert W Baker; Mauricio Tohen
Olanzapine versus placebo in acute mania: treatment responses in subgroups.
Journal of clinical psychopharmacology 2003;23(4):370-6.
2003: Carol A Glod; Arlene Lynch; Elizabeth Flynn; Cynthia Berkowitz; Ross J Baldessarini
Open trial of bupropion SR in adolescent major depression.
Journal of child and adolescent psychiatric nursing : official publication of the Association of Child and Adolescent Psychiatric Nurses, Inc 2003;16(3):123-30.
2003: Franca Centorrino; Matthew J Albert; G Drago-Ferrante; Athanasios Koukopoulos; Judith M Berry; Ross J Baldessarini
Delirium during clozapine treatment: incidence and associated risk factors.
Pharmacopsychiatry 2003;36(4):156-60.
2003: Franca Centorrino; James Patrick Kelleher; Judith M Berry; Paola Salvatore; Marion Eakin; Kate V Fogarty; Veronica Fellman; Ross J Baldessarini
Pilot comparison of extended-release and standard preparations of divalproex sodium in patients with bipolar and schizoaffective disorders.
The American journal of psychiatry 2003;160(7):1348-50.
2003: Leonardo Tondo; John Hennen; Ross J Baldessarini
Rapid-cycling bipolar disorder: effects of long-term treatments.
Acta psychiatrica Scandinavica 2003;108(1):4-14.
2003: Ross J Baldessarini; Leonardo Tondo; John Hennen
Treatment-latency and previous episodes: relationships to pretreatment morbidity and response to maintenance treatment in bipolar I and II disorders.
Bipolar disorders 2003;5(3):169-79.
2003: Ross J Baldessarini
Assessment of treatment response in mania: commentary and new findings.
Bipolar disorders 2003;5(2):79-84.
2003: Eugen Davids; Kehong Zhang; Frank I Tarazi; Ross J Baldessarini
Animal models of attention-deficit hyperactivity disorder.
Brain research. Brain research reviews 2003;42(1):1-21.
2003: Hadine Joffe; Janet E Hall; Lee S Cohen; Ann E Taylor; Ross J Baldessarini
A putative relationship between valproic acid and polycystic ovarian syndrome: implications for treatment of women with seizure and bipolar disorders.
Harvard review of psychiatry 2003;11(2):99-108.
2003: Christopher Baethge; Paola Salvatore; Ross J Baldessarini
"On cyclic insanity" by Karl Ludwig Kahlbaum, MD: a translation and commentary.
Harvard review of psychiatry 2003;11(2):78-90.
2003: Jean A Frazier; Louise Glassner Cohen; Leslie Jacobsen; Dale Grothe; James G Flood; Ross J Baldessarini; Stephen Piscitelli; Grace S Kim; Judy Rapoport
Clozapine pharmacokinetics in children and adolescents with childhood-onset schizophrenia.
Journal of clinical psychopharmacology 2003;23(1):87-91.
2003: Leonardo Tondo; Göran Isacsson; Ross J Baldessarini
Suicidal behaviour in bipolar disorder: risk and prevention.
CNS drugs 2003;17(7):491-511.
2003: Ross J Baldessarini; Leonardo Tondo; John Hennen
Lithium treatment and suicide risk in major affective disorders: update and new findings.
The Journal of clinical psychiatry 2003;64 Suppl 5():44-52.
2002: Adele C Viguera; Lee S Cohen; Suzanne Bouffard; Theodore Whitfield; Ross J Baldessarini
Reproductive decisions by women with bipolar disorder after prepregnancy psychiatric consultation.
The American journal of psychiatry 2002;159(12):2102-4.
2002: Frank I Tarazi; Kehong Zhang; Ross J Baldessarini
Long-term effects of newer antipsychotic drugs on neuronal nitric oxide synthase in rat brain.
Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2002;7(4):297-300.
2002: Franca Centorrino; Marion Eakin; Won-Myong Bahk; James Patrick Kelleher; Jessica Goren; Paola Salvatore; Samy Egli; Ross J Baldessarini
Inpatient antipsychotic drug use in 1998, 1993, and 1989.
The American journal of psychiatry 2002;159(11):1932-5.
2002: Adele C Viguera; Lee J Cohen; Leonardo Tondo; Ross J Baldessarini
Protective effect of pregnancy on the course of lithium-responsive bipolar I disorder.
Journal of affective disorders 2002;72(1):107-8; author reply 103-5.
2002: Paola Salvatore; Ross J Baldessarini; Franca Centorrino; Samy Egli; Matthew Albert; Angela Gerhard; Carlo Maggini
Weygandt's On the Mixed States of Manic-Depressive Insanity: a translation and commentary on its significance in the evolution of the concept of bipolar disorder.
Harvard review of psychiatry 2002;10(5):255-75.
2002: Kehong Zhang; Eugen Davids; Frank I Tarazi; Ross J Baldessarini
Serotonin transporter binding increases in caudate-putamen and nucleus accumbens after neonatal 6-hydroxydopamine lesions in rats: implications for motor hyperactivity.
Brain research. Developmental brain research 2002;137(2):135-8.
2002: Ross J Baldessarini; S Nassir Ghaemi; Adele C Viguera
Tolerance in antidepressant treatment.
Psychotherapy and psychosomatics 2002;71(4):177-9.
2002: Meng-Yang Zhu; Chun-Hyung Kim; Dong-Youn Hwang; Ross J Baldessarini; Kwang-Soo Kim
Effects of desipramine treatment on norepinephrine transporter gene expression in the cultured SK-N-BE(2)M17 cells and rat brain tissue.
Journal of neurochemistry 2002;82(1):146-53.
2002: Adele C Viguera; Lee S Cohen; Ross J Baldessarini; Ruta Nonacs
Managing bipolar disorder during pregnancy: weighing the risks and benefits.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2002;47(5):426-36.
2002: Eugen Davids; Kehong Zhang; Nora S Kula; Frank I Tarazi; Ross J Baldessarini
Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats.
The Journal of pharmacology and experimental therapeutics 2002;301(3):1097-102.
2002: XINGZHENG FU; Ping-Zhong Tan; Nora S Kula; Ross J Baldessarini; Gilles Tamagnan; Robert B Innis; Ronald M Baldwin
Synthesis, receptor potency, and selectivity of halogenated diphenylpiperidines as serotonin 5-HT2A ligands for PET or SPECT brain imaging.
Journal of medicinal chemistry 2002;45(11):2319-24.
2002: Frank I Tarazi; Kehong Zhang; Ross J Baldessarini
Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions.
Psychopharmacology 2002;161(3):263-70.
2002: Kehong Zhang; Frank I Tarazi; Eugen Davids; Ross J Baldessarini
Plasticity of dopamine D4 receptors in rat forebrain: temporal association with motor hyperactivity following neonatal 6-hydroxydopamine lesioning.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;26(5):625-33.
2002: Kehong Zhang; Eugen Davids; Frank I Tarazi; Ross J Baldessarini
Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions.
Psychopharmacology 2002;161(1):100-6.
2002: Ross J Baldessarini; Leonardo Tondo; John Hennen; Adele C Viguera
Is lithium still worth using? An update of selected recent research.
Harvard review of psychiatry 2002;10(2):59-75.
2002: Eugen Davids; Kehong Zhang; Frank I Tarazi; Ross J Baldessarini
Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning.
Psychopharmacology 2002;160(1):92-8.
2002: Ross J Baldessarini
Treatment research in bipolar disorder: issues and recommendations.
CNS drugs 2002;16(11):721-9.
2002: James Patrick Kelleher; Franca Centorrino; Matthew J Albert; Ross J Baldessarini
Advances in atypical antipsychotics for the treatment of schizophrenia: new formulations and new agents.
CNS drugs 2002;16(4):249-61.
2002: Richard R Cesati; Gilles Tamagnan; Ronald M Baldwin; Sami S Zoghbi; Robert B Innis; Nora S Kula; Ross J Baldessarini; John A Katzenellenbogen
Synthesis of cyclopentadienyltricarbonyl rhenium phenyltropanes by double ligand transfer: organometallic ligands for the dopamine transporter.
Bioconjugate chemistry 2002;13(1):29-39.
2002: Franca Centorrino; Bruce H Price; Margaret Tuttle; Won-Myong Bahk; John Hennen; Matthew J Albert; Ross J Baldessarini
EEG abnormalities during treatment with typical and atypical antipsychotics.
The American journal of psychiatry 2002;159(1):109-15.
2002: Daniel Tarsy; Ross J Baldessarini; Frank I Tarazi
Effects of newer antipsychotics on extrapyramidal function.
CNS drugs 2002;16(1):23-45.
2001: Xiao-Hui Gu; Rushi Zong; Nora S Kula; Ross J Baldessarini; John L Neumeyer
Synthesis and biological evaluation of a series of novel N- or O-fluoroalkyl derivatives of tropane: potential positron emission tomography (PET) imaging agents for the dopamine transporter.
Bioorganic & medicinal chemistry letters 2001;11(23):3049-53.
2001: Kehong Zhang; Frank I Tarazi; Ross J Baldessarini
Role of dopamine D(4) receptors in motor hyperactivity induced by neonatal 6-hydroxydopamine lesions in rats.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;25(5):624-32.
2001: Adele C Viguera; Ross J Baldessarini; Leonardo Tondo
Response to lithium maintenance treatment in bipolar disorders: comparison of women and men.
Bipolar disorders 2001;3(5):245-52.
2001: Leonardo Tondo; John Hennen; Ross J Baldessarini
Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis.
Acta psychiatrica Scandinavica 2001;104(3):163-72.
2001: S Nassir Ghaemi; M S Lenox; Ross J Baldessarini
Effectiveness and safety of long-term antidepressant treatment in bipolar disorder.
The Journal of clinical psychiatry 2001;62(7):565-9.
2001: Leonardo Tondo; Ross J Baldessarini; G Floris
Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders.
The British journal of psychiatry. Supplement 2001;41():s184-90.
2001: Kehong Zhang; Frank I Tarazi; Ross J Baldessarini
Nigrostriatal dopaminergic denervation enhances dopamine D(4) receptor binding in rat caudate-putamen.
Pharmacology, biochemistry, and behavior 2001;69(1-2):111-6.
2001: Frank I Tarazi; Kehong Zhang; Ross J Baldessarini
Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment.
The Journal of pharmacology and experimental therapeutics 2001;297(2):711-7.
2001: Ross J Baldessarini; Leonardo Tondo; J Hennen
Treating the suicidal patient with bipolar disorder. Reducing suicide risk with lithium.
Annals of the New York Academy of Sciences 2001;932():24-38; discussion 39-43.
2001: Franca Centorrino; M A Hernán; G Drago-Ferrante; M Rendall; A Apicella; G Längar; Ross J Baldessarini
Factors associated with noncompliance with psychiatric outpatient visits.
Psychiatric services (Washington, D.C.) 2001;52(3):378-80.
2001: Ross J Baldessarini; A Campbell; Nigel L Webb; Charles S Swindell; James G Flood; V E Shashoua; Nora S Kula; S Hemamalini; Matthews O Bradley
Fatty acid derivatives of clozapine: prolonged antidopaminergic activity of docosahexaenoylclozapine in the rat.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;24(1):55-65.
2000: Ross J Baldessarini; Leonardo Tondo; G Floris; John Hennen
Effects of rapid cycling on response to lithium maintenance treatment in 360 bipolar I and II disorder patients.
Journal of affective disorders 2000;61(1-2):13-22.
2000: Frank I Tarazi; Kehong Zhang; Ross J Baldessarini
Effects of nigrostriatal dopamine denervation on ionotropic glutamate receptors in rat caudate-putamen.
Brain research 2000;881(1):69-72.
2000: Mauricio Tohen; Stephen M Strakowski; Carlos A Zarate; John Hennen; Andrew L Stoll; Trisha Suppes; Gianni Faedda; Bruce M Cohen; Priscilla Gebre-Medhin; Ross J Baldessarini
The McLean-Harvard first-episode project: 6-month symptomatic and functional outcome in affective and nonaffective psychosis.
Biological psychiatry 2000;48(6):467-76.
2000: N A Huxley; sagar parikh; Ross J Baldessarini
Effectiveness of psychosocial treatments in bipolar disorder: state of the evidence.
Harvard review of psychiatry 2000;8(3):126-40.
2000: Adele C Viguera; Leonardo Tondo; Ross J Baldessarini
Sex differences in response to lithium treatment.
The American journal of psychiatry 2000;157(9):1509-11.
2000: Frank I Tarazi; Nora S Kula; Kehong Zhang; Ross J Baldessarini
Alkylation of rat dopamine transporters and blockade of dopamine uptake by EEDQ.
Neuropharmacology 2000;39(11):2133-8.
2000: Gilles Tamagnan; Ronald M Baldwin; Nora S Kula; Ross J Baldessarini; Robert B Innis
Synthesis and monoamine transporter affinity of 2beta-carbomethoxy-3beta-(2''-, 3''- or 4''-substituted) biphenyltropanes.
Bioorganic & medicinal chemistry letters 2000;10(16):1783-5.
2000: Frank I Tarazi; Kehong Zhang; Ross J Baldessarini
Olanzapine, quetiapine, and risperidone: long-term effects on monoamine transporters in rat forebrain.
Neuroscience letters 2000;287(2):81-4.
2000: Gilles Tamagnan; Ronald M Baldwin; Nora S Kula; Ross J Baldessarini; Robert B Innis
Cyclopentadienyltricarbonylrheniumbenzazepines: synthesis and binding affinity.
Bioorganic & medicinal chemistry letters 2000;10(10):1113-5.
2000: Ross J Baldessarini; Mauricio Tohen; Leonardo Tondo
Maintenance treatment in bipolar disorder.
Archives of general psychiatry 2000;57(5):490-2.
2000: Ross J Baldessarini
A plea for integrity of the bipolar disorder concept.
Bipolar disorders 2000;2(1):3-7.
2000: Frank I Tarazi; Ross J Baldessarini
Comparative postnatal development of dopamine D(1), D(2) and D(4) receptors in rat forebrain.
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 2000;18(1):29-37.
2000: Mauricio Tohen; John Hennen; C M Zarate; Ross J Baldessarini; Stephen M Strakowski; Andrew L Stoll; Gianni Faedda; Trisha Suppes; Priscilla Gebre-Medhin; Bruce M Cohen
Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features.
The American journal of psychiatry 2000;157(2):220-8.
2000: Adele C Viguera; Ruta Nonacs; Lee S Cohen; Leonardo Tondo; A Murray; Ross J Baldessarini
Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance.
The American journal of psychiatry 2000;157(2):179-84.
2000: Ross J Baldessarini; Leonardo Tondo
Does lithium treatment still work? Evidence of stable responses over three decades.
Archives of general psychiatry 2000;57(2):187-90.
2000: Kehong Zhang; Frank I Tarazi; A Campbell; Ross J Baldessarini
GABA(B) receptors: altered coupling to G-proteins in rats sensitized to amphetamine.
Neuroscience 2000;101(1):5-10.
2000: Leonardo Tondo; Ross J Baldessarini
Reduced suicide risk during lithium maintenance treatment.
The Journal of clinical psychiatry 2000;61 Suppl 9():97-104.
2000: Kehong Zhang; Frank I Tarazi; Ross J Baldessarini
Dopamine D(4) receptors in rat forebrain: unchanged with amphetamine-induced behavioral sensitization.
Neuroscience 2000;97(2):211-3.
1999: Ross J Baldessarini; Leonardo Tondo; John Hennen; G Floris
Latency and episodes before treatment: response to lithium maintenance in bipolar I and II disorders.
Bipolar disorders 1999;1(2):91-7.
1999: Kehong Zhang; N T Weiss; Frank I Tarazi; Nora S Kula; Ross J Baldessarini
Effects of alkylating agents on dopamine D(3) receptors in rat brain: selective protection by dopamine.
Brain research 1999;847(1):32-7.
1999: Frank I Tarazi; Ross J Baldessarini
Dopamine D4 receptors: significance for molecular psychiatry at the millennium.
Molecular psychiatry 1999;4(6):529-38.
1999: Ross J Baldessarini; Leonardo Tondo; Adele C Viguera
Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications.
Bipolar disorders 1999;1(1):17-24.
1999: Ross J Baldessarini; Leonardo Tondo; John Hennen
Treatment delays in bipolar disorders.
The American journal of psychiatry 1999;156(5):811-2.
1999: Frank I Tarazi; Ross J Baldessarini
Regional localization of dopamine and ionotropic glutamate receptor subtypes in striatolimbic brain regions.
Journal of neuroscience research 1999;55(4):401-10.
1999: Nora S Kula; Frank I Tarazi; Ross J Baldessarini; L Xu; V Bakthavachalam; S Pounds; C D True
Neuropharmacological assessment of potential dopamine D4 receptor-selective radioligands.
European journal of pharmacology 1999;367(1):139-42.
1999: Frank I Tarazi; EC Tomasini; Ross J Baldessarini
Postnatal development of dopamine D1-like receptors in rat cortical and striatolimbic brain regions: An autoradiographic study.
Developmental neuroscience 1999;21(1):43-9.
1999: Ross J Baldessarini; Kay Redfield Jamison
Effects of medical interventions on suicidal behavior. Summary and conclusions.
The Journal of clinical psychiatry 1999;60 Suppl 2():117-22.
1999: Ross J Baldessarini; Leonardo Tondo; John Hennen
Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders.
The Journal of clinical psychiatry 1999;60 Suppl 2():77-84; discussion 111-6.
1999: Leonardo Tondo; Ross J Baldessarini; John Hennen; G P Minnai; P Salis; L Scamonatti; M Masia; Carmen Ghiani; P Mannu
Suicide attempts in major affective disorder patients with comorbid substance use disorders.
The Journal of clinical psychiatry 1999;60 Suppl 2():63-9; discussion 75-6, 113-6.
1998: Frank I Tarazi; A Campbell; Ross J Baldessarini
Effects of hippocampal kainic acid lesions on striatolimbic dopamine D1-, D2-, and D4-like receptors.
Neuroscience 1998;87(1):1-4.
1998: Leonardo Tondo; Ross J Baldessarini
Rapid cycling in women and men with bipolar manic-depressive disorders.
The American journal of psychiatry 1998;155(10):1434-6.
1998: Frank I Tarazi; EC Tomasini; Ross J Baldessarini
Postnatal development of dopamine D4-like receptors in rat forebrain regions: comparison with D2-like receptors.
Brain research. Developmental brain research 1998;110(2):227-33.
1998: Frank I Tarazi; A Campbell; SK Yeghiayan; Ross J Baldessarini
Localization of ionotropic glutamate receptors in caudate-putamen and nucleus accumbens septi of rat brain: comparison of NMDA, AMPA, and kainate receptors.
Synapse (New York, N.Y.) 1998;30(2):227-35.
1998: Frank I Tarazi; EC Tomasini; Ross J Baldessarini
Postnatal development of dopamine and serotonin transporters in rat caudate-putamen and nucleus accumbens septi.
Neuroscience letters 1998;254(1):21-4.
1998: Leonardo Tondo; Ross J Baldessarini; John Hennen; Giovanni Floris; F Silvetti; M Tohen
Lithium treatment and risk of suicidal behavior in bipolar disorder patients.
The Journal of clinical psychiatry 1998;59(8):405-14.
1998: Frank I Tarazi; A Campbell; Ross J Baldessarini
Effects of hippocampal lesions on striatolimbic ionotropic glutamatergic receptors.
Neuroscience letters 1998;250(1):13-6.
1998: Martin H Teicher; Susan L Andersen; A Campbell; H A Gelbard; Ross J Baldessarini
Progressive accumbens degeneration after neonatal striatal 6-hydroxydopamine in rats.
Neuroscience letters 1998;247(2-3):99-102.
1998: SK Yeghiayan; M A Gongwer; Ross J Baldessarini; Nora S Kula; Rushi Zong; John L Neumeyer
Local injection of alkylating and nonalkylating dopamine receptor antagonists into rat basal forebrain: autoradiographic assessment of D2-like and D3 sites.
Brain research 1998;792(2):324-6.
1998: Frank I Tarazi; SK Yeghiayan; John L Neumeyer; Ross J Baldessarini
Medial prefrontal cortical D2 and striatolimbic D4 dopamine receptors: common targets for typical and atypical antipsychotic drugs.
Progress in neuro-psychopharmacology & biological psychiatry 1998;22(4):693-707.
1998: Leonardo Tondo; Ross J Baldessarini; John Hennen; G Floris
Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders.
The American journal of psychiatry 1998;155(5):638-45.
1998: Adele C Viguera; Ross J Baldessarini; J Friedberg
Discontinuing antidepressant treatment in major depression.
Harvard review of psychiatry 1998;5(6):293-306.
1998: Frank I Tarazi; A Campbell; SK Yeghiayan; Ross J Baldessarini
Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2-, and D4-like receptors.
Neuroscience 1998;83(1):169-76.
1997: Leonardo Tondo; Kay Redfield Jamison; Ross J Baldessarini
Effect of lithium maintenance on suicidal behavior in major mood disorders.
Annals of the New York Academy of Sciences 1997;836():339-51.
1997: Frank I Tarazi; Nora S Kula; Ross J Baldessarini
Regional distribution of dopamine D4 receptors in rat forebrain.
Neuroreport 1997;8(16):3423-6.
1997: SK Yeghiayan; Susan L Andersen; Ross J Baldessarini
Lack of effect of chronic clorgyline or selegiline on dopamine and serotonin transporters in rat caudate-putamen or nucleus accumbens septi.
Neuroscience letters 1997;236(3):147-50.
1997: A Campbell; A T Villavicencio; SK Yeghiayan; R Balikian; Ross J Baldessarini
Mapping of locomotor behavioral arousal induced by microinjections of dopamine within nucleus accumbens septi of rat forebrain.
Brain research 1997;771(1):55-62.
1997: Frank I Tarazi; SK Yeghiayan; Ross J Baldessarini; Nora S Kula; John L Neumeyer
Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1997;17(3):186-96.
1997: Nora S Kula; Ross J Baldessarini; J W Kebabian; V Bakthavachalam; L Xu
RBI-257: a highly potent dopamine D4 receptor-selective ligand.
European journal of pharmacology 1997;331(2-3):333-6.
1997: Ross J Baldessarini; J D Hegarty; ED Bird; Francine M Benes
Meta-analysis of postmortem studies of Alzheimer's disease-like neuropathology in schizophrenia.
The American journal of psychiatry 1997;154(6):861-3.
1997: J A Bodkin; R A Lasser; James D Wines; D M Gardner; Ross J Baldessarini
Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy.
The Journal of clinical psychiatry 1997;58(4):137-45.
1997: Ross J Baldessarini; Leonardo Tondo; G Floris; N Rudas
Reduced morbidity after gradual discontinuation of lithium treatment for bipolar I and II disorders: a replication study.
The American journal of psychiatry 1997;154(4):551-3.
1997: Leonardo Tondo; Ross J Baldessarini; G Floris; N Rudas
Effectiveness of restarting lithium treatment after its discontinuation in bipolar I and bipolar II disorders.
The American journal of psychiatry 1997;154(4):548-50.
1997: R A Lasser; Ross J Baldessarini
Thyroid hormones in depressive disorders: a reappraisal of clinical utility.
Harvard review of psychiatry 1997;4(6):291-305.
1997: SK Yeghiayan; A E Kelley; Nora S Kula; A Campbell; Ross J Baldessarini
Role of dopamine in behavioral effects of serotonin microinjected into rat striatum.
Pharmacology, biochemistry, and behavior 1997;56(2):251-9.
1997: A C Viguera; Ross J Baldessarini; J D Hegarty; D P van Kammen; Mauricio Tohen
Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment.
Archives of general psychiatry 1997;54(1):49-55.
1996: M C Meyer; Ross J Baldessarini; D C Goff; F Centorrino
Clinically significant interactions of psychotropic agents with antipsychotic drugs.
Drug safety : an international journal of medical toxicology and drug experience 1996;15(5):333-46.
1996: Ross J Baldessarini; Leonardo Tondo; Gianni Faedda; Trisha Suppes; G Floris; N Rudas
Effects of the rate of discontinuing lithium maintenance treatment in bipolar disorders.
The Journal of clinical psychiatry 1996;57(10):441-8.
1996: F Centorrino; Ross J Baldessarini; Frances R Frankenburg; J Kando; S A Volpicelli; J G Flood
Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors.
The American journal of psychiatry 1996;153(6):820-2.
1996: Ross J Baldessarini; Frank I Tarazi
Brain dopamine receptors: a primer on their current status, basic and clinical.
Harvard review of psychiatry 1996;3(6):301-25.
1995: SD Wyrick; Raymond G Booth; A M Myers; C E Owens; E C Bucholtz; P C Hooper; Nora S Kula; Ross J Baldessarini; Richard B Mailman
1-Phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes and related derivatives as ligands for the neuromodulatory sigma 3 receptor: further structure-activity relationships.
Journal of medicinal chemistry 1995;38(19):3857-64.
1995: Ross J Baldessarini; J C Kando; F Centorrino
Hospital use of antipsychotic agents in 1989 and 1993: stable dosing with decreased length of stay.
The American journal of psychiatry 1995;152(7):1038-44.
1995: F Centorrino; Ross J Baldessarini; J G Flood; J C Kando; Frances R Frankenburg
Relation of leukocyte counts during clozapine treatment to serum concentrations of clozapine and metabolites.
The American journal of psychiatry 1995;152(4):610-2.
1995: Mauricio Tohen; J Castillo; Ross J Baldessarini; CA Zarate; J C Kando
Blood dyscrasias with carbamazepine and valproate: a pharmacoepidemiological study of 2,228 patients at risk.
The American journal of psychiatry 1995;152(3):413-8.
1994: A M Myers; P S Charifson; C E Owens; Nora S Kula; Andrew T McPhail; Ross J Baldessarini; Raymond G Booth; SD Wyrick
Conformational analysis, pharmacophore identification, and comparative molecular field analysis of ligands for the neuromodulatory sigma 3 receptor.
Journal of medicinal chemistry 1994;37(24):4109-17.
1994: Raymond G Booth; Ross J Baldessarini; E Marsh; C E Owens
Actions of (+/-)-7-hydroxy-N,N-dipropylaminotetralin (7-OH-DPAT) on dopamine synthesis in limbic and extrapyramidal regions of rat brain.
Brain research 1994;662(1-2):283-8.
1994: J D Hegarty; Ross J Baldessarini; Mauricio Tohen; C Waternaux; G Oepen
One hundred years of schizophrenia: a meta-analysis of the outcome literature.
The American journal of psychiatry 1994;151(10):1409-16.
1994: Ross J Baldessarini; A Campbell; N Ben-Jonathan; J Ellingboe; R Zong; John L Neumeyer
Effects of aporphine isomers on rat prolactin.
Neuroscience letters 1994;176(2):269-71.
1994: Ross J Baldessarini; E R Marsh; D Huston-Lyons
Effects of dopamine partial-agonist aminoergolines on dopamine metabolism in limbic and extrapyramidal regions of rat brain.
Biochemical pharmacology 1994;47(10):1917-9.
1994: F Centorrino; Ross J Baldessarini; J C Kando; Frances R Frankenburg; S A Volpicelli; J G Flood
Clozapine and metabolites: concentrations in serum and clinical findings during treatment of chronically psychotic patients.
Journal of clinical psychopharmacology 1994;14(2):119-25.
1994: Ross J Baldessarini; Nora S Kula; R Zong; John L Neumeyer
Receptor affinities of aporphine enantiomers in rat brain tissue.
European journal of pharmacology 1994;254(1-2):199-203.
1994: F Centorrino; Ross J Baldessarini; J Kando; Frances R Frankenburg; S A Volpicelli; P R Puopolo; J G Flood
Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate.
The American journal of psychiatry 1994;151(1):123-5.
1993: Raymond G Booth; SD Wyrick; Ross J Baldessarini; Nora S Kula; A M Myers; Richard B Mailman
New sigma-like receptor recognized by novel phenylaminotetralins: ligand binding and functional studies.
Molecular pharmacology 1993;44(6):1232-9.
1993: Trisha Suppes; Ross J Baldessarini; Gianni Faedda; Leonardo Tondo; Mauricio Tohen
Discontinuation of maintenance treatment in bipolar disorder: risks and implications.
Harvard review of psychiatry 1993;1(3):131-44.
1993: Martin H Teicher; N I Barber; H A Gelbard; A L Gallitano; A Campbell; E Marsh; Ross J Baldessarini
Developmental differences in acute nigrostriatal and mesocorticolimbic system response to haloperidol.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1993;9(2):147-56.
1993: Ross J Baldessarini; F Centorrino; J G Flood; S A Volpicelli; D Huston-Lyons; B M Cohen
Tissue concentrations of clozapine and its metabolites in the rat.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1993;9(2):117-24.
1993: SD Wyrick; Raymond G Booth; A M Myers; C E Owens; Nora S Kula; Ross J Baldessarini; Andrew T McPhail; Richard B Mailman
Synthesis and pharmacological evaluation of 1-phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes as ligands for a novel receptor with sigma-like neuromodulatory activity.
Journal of medicinal chemistry 1993;36(17):2542-51.
1993: Ross J Baldessarini; Nora S Kula; C R McGrath; V Bakthavachalam; J W Kebabian; John L Neumeyer
Isomeric selectivity at dopamine D3 receptors.
European journal of pharmacology 1993;239(1-3):269-70.
1993: S A Volpicelli; F Centorrino; P R Puopolo; J Kando; Frances R Frankenburg; Ross J Baldessarini; J G Flood
Determination of clozapine, norclozapine, and clozapine-N-oxide in serum by liquid chromatography.
Clinical chemistry 1993;39(8):1656-9.
1993: T E Wilens; Joseph Biederman; Ross J Baldessarini; P R Puopolo; J G Flood
Electrocardiographic effects of desipramine and 2-hydroxydesipramine in children, adolescents, and adults treated with desipramine.
Journal of the American Academy of Child and Adolescent Psychiatry 1993;32(4):798-804.
1993: Gianni Faedda; Leonardo Tondo; Ross J Baldessarini; Trisha Suppes; Mauricio Tohen
Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders.
Archives of general psychiatry 1993;50(6):448-55.
1993: Gianni Faedda; Leonardo Tondo; Martin H Teicher; Ross J Baldessarini; H A Gelbard; G F Floris
Seasonal mood disorders. Patterns of seasonal recurrence in mania and depression.
Archives of general psychiatry 1993;50(1):17-23.
1993: A Campbell; Ross J Baldessarini; John L Neumeyer
Altered spontaneous behavior and sensitivity to apomorphine in rats following pretreatment with S(+)-aporphines or fluphenazine.
Psychopharmacology 1993;111(3):351-8.
1992: Ross J Baldessarini; Nora S Kula; A Campbell; V Bakthavachalam; J Yuan; John L Neumeyer
Prolonged D2 antidopaminergic activity of alkylating and nonalkylating derivatives of spiperone in rat brain.
Molecular pharmacology 1992;42(5):856-63.
1992: A Campbell; Ross J Baldessarini; SK Yeghiayan
Antagonism of limbic and extrapyramidal actions of intracerebrally injected dopamine by ergolines with partial D2 agonist activity in the rat.
Brain research 1992;592(1-2):348-52.
1992: T E Wilens; Joseph Biederman; Ross J Baldessarini; S P McDermott; P R Puopolo; J G Flood
Fluoxetine inhibits desipramine metabolism.
Archives of general psychiatry 1992;49(9):752.
1992: T E Wilens; Joseph Biederman; Ross J Baldessarini; P R Puopolo; J G Flood
Developmental changes in serum concentrations of desipramine and 2-hydroxydesipramine during treatment with desipramine.
Journal of the American Academy of Child and Adolescent Psychiatry 1992;31(4):691-8.
1992: Ross J Baldessarini; E R Marsh; Nora S Kula
Interactions of fluoxetine with metabolism of dopamine and serotonin in rat brain regions.
Brain research 1992;579(1):152-6.
1992: Ross J Baldessarini; D Huston-Lyons; A Campbell; E Marsh; B M Cohen
Do central antiadrenergic actions contribute to the atypical properties of clozapine?
The British journal of psychiatry. Supplement 1992;(17):12-6.
1992: Nora S Kula; T George; Ross J Baldessarini
Rate of recovery of D1 and D2 dopaminergic receptors in young vs. adult rat striatal tissue following alkylation with ethoxycarbonyl-ethoxy-dihydroquinoline (EEDQ).
Brain research. Developmental brain research 1992;66(2):286-9.
1992: John L Neumeyer; Nora S Kula; Ross J Baldessarini; N Baindur
Stereoisomeric probes for the D1 dopamine receptor: synthesis and characterization of R-(+) and S-(-) enantiomers of 3-allyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine and its 6-bromo analogue.
Journal of medicinal chemistry 1992;35(8):1466-71.
1992: John L Neumeyer; N Baindur; V Bakthavachalam; J Yuan; Bertha K Madras; Nora S Kula; A Campbell; Ross J Baldessarini
Alan Horn Memorial Lecture. Selective probes for characterization of dopamine D1 and D2 receptors.
Neurochemistry international 1992;20 Suppl():63S-68S.
1991: Trisha Suppes; Ross J Baldessarini; Gianni Faedda; Mauricio Tohen
Risk of recurrence following discontinuation of lithium treatment in bipolar disorder.
Archives of general psychiatry 1991;48(12):1082-8.
1991: Martin H Teicher; A L Gallitano; H A Gelbard; H K Evans; E R Marsh; Raymond G Booth; Ross J Baldessarini
Dopamine D1 autoreceptor function: possible expression in developing rat prefrontal cortex and striatum.
Brain research. Developmental brain research 1991;63(1-2):229-35.
1991: A Satlin; Martin H Teicher; Harris R Lieberman; Ross J Baldessarini; Ladislav Volicer; Y Rheaume
Circadian locomotor activity rhythms in Alzheimer's disease.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1991;5(2):115-26.
1991: Gianni Faedda; Ross J Baldessarini; Mauricio Tohen; Stephen M Strakowski; C Waternaux
Episode sequence in bipolar disorder and response to lithium treatment.
The American journal of psychiatry 1991;148(9):1237-9.
1991: Raymond G Booth; Ross J Baldessarini
(+)-6,7-benzomorphan sigma ligands stimulate dopamine synthesis in rat corpus striatum tissue.
Brain research 1991;557(1-2):349-52.
1991: Raymond G Booth; Ross J Baldessarini; A Campbell
Inhibition of dopamine synthesis in rat striatal minces: evidence of dopamine autoreceptor supersensitivity to S(+)- but not R(-)-N-n-propylnorapomorphine after pretreatment with fluphenazine.
Biochemical pharmacology 1991;41(12):2040-3.
1991: Ross J Baldessarini; Frances R Frankenburg
Clozapine. A novel antipsychotic agent.
The New England journal of medicine 1991;324(11):746-54.
1991: Nora S Kula; Ross J Baldessarini
Lack of increase in dopamine transporter binding or function in rat brain tissue after treatment with blockers of neuronal uptake of dopamine.
Neuropharmacology 1991;30(1):89-92.
1991: A Campbell; SK Yeghiayan; Ross J Baldessarini; John L Neumeyer
Selective antidopaminergic effects of S(+)N-n-propylnoraporphines in limbic versus extrapyramidal sites in rat brain: comparisons with typical and atypical antipsychotic agents.
Psychopharmacology 1991;103(3):323-9.
1991: Ross J Baldessarini; Nora S Kula; Y Gao; A Campbell; John L Neumeyer
R(-)2-fluoro-N-n-propylnorapomorphine: a very potent and D2-selective dopamine agonist.
Neuropharmacology 1991;30(1):97-9.
1991: John L Neumeyer; Y G Gao; Nora S Kula; Ross J Baldessarini
R and S enantiomers of 11-hydroxy- and 10,11-dihydroxy-N-allylnoraporphine: synthesis and affinity for dopamine receptors in rat brain tissue.
Journal of medicinal chemistry 1991;34(1):24-8.
1990: John L Neumeyer; Y G Gao; Nora S Kula; Ross J Baldessarini
Synthesis and dopamine receptor affinity of (R)-(-)-2-fluoro-N-n-propylnorapomorphine: a highly potent and selective dopamine D2 agonist.
Journal of medicinal chemistry 1990;33(12):3122-4.
1990: H A Gelbard; Martin H Teicher; Ross J Baldessarini; A Gallitano; E R Marsh; J Zorc; Gianni Faedda
Dopamine D1 receptor development depends on endogenous dopamine.
Brain research. Developmental brain research 1990;56(1):137-40.
1990: Raymond G Booth; Ross J Baldessarini
Adenosine A2 stimulation of tyrosine hydroxylase in rat striatal minces is reversed by dopamine D2 autoreceptor activation.
European journal of pharmacology 1990;185(2-3):217-21.
1990: Ross J Baldessarini; E R Marsh; Nora S Kula; R S Zong; Y G Gao; John L Neumeyer
Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions.
Biochemical pharmacology 1990;40(3):417-23.
1990: Raymond G Booth; Ross J Baldessarini; Nora S Kula; Y Gao; R Zong; John L Neumeyer
Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
Molecular pharmacology 1990;38(1):92-101.
1990: A Campbell; Ross J Baldessarini; Y Gao; R Zong; John L Neumeyer
R(-) and S(+) stereoisomers of 11-hydroxy- and 11-methoxy-N-n-propylnoraporphine: central dopaminergic behavioral activity in the rat.
Neuropharmacology 1990;29(6):527-36.
1990: Y G Gao; Ross J Baldessarini; Nora S Kula; John L Neumeyer
Synthesis and dopamine receptor affinities of enantiomers of 2-substituted apomorphines and their N-n-propyl analogues.
Journal of medicinal chemistry 1990;33(6):1800-5.
1990: Y G Gao; V J Ram; A Campbell; Nora S Kula; Ross J Baldessarini; John L Neumeyer
Synthesis and structural requirements of N-substituted norapomorphines for affinity and activity at dopamine D-1, D-2, and agonist receptor sites in rat brain.
Journal of medicinal chemistry 1990;33(1):39-44.
1989: A Campbell; Ross J Baldessarini; C Cremens; Martin H Teicher; E Marsh; Nora S Kula
Bromocriptine antagonizes behavioral effects of cocaine in the rat.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1989;2(3):209-24.
1989: H A Gelbard; Martin H Teicher; Gianni Faedda; Ross J Baldessarini
Postnatal development of dopamine D1 and D2 receptor sites in rat striatum.
Brain research. Developmental brain research 1989;49(1):123-30.
1989: Ross J Baldessarini
Current status of antidepressants: clinical pharmacology and therapy.
The Journal of clinical psychiatry 1989;50(4):117-26.
1989: Gianni Faedda; Nora S Kula; Ross J Baldessarini
Pharmacology of binding of 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue.
Biochemical pharmacology 1989;38(3):473-80.
1989: N I Barber; M H Teicher; Ross J Baldessarini
Effects of selective monoaminergic reuptake blockade on activity rhythms in developing rats.
Psychopharmacology 1989;97(3):343-8.
1988: T M Trainor; Paul Vouros; P Lampen; John L Neumeyer; Ross J Baldessarini; Nora S Kula
Determination of N-n-propylnorapomorphine in serum and brain tissue by gas chromatography-negative ion chemical ionization mass spectrometry.
Journal of chromatography 1988;457():257-66.
1988: Martin H Teicher; B M Cohen; Ross J Baldessarini; J O Cole
Severe daytime somnolence in patients treated with an MAOI.
The American journal of psychiatry 1988;145(12):1552-6.
1988: A Campbell; Ross J Baldessarini; M C Cremens
Dose-catalepsy response to haloperidol in rat: effects of strain and sex.
Neuropharmacology 1988;27(11):1197-9.
1988: Martin H Teicher; J M Lawrence; N I Barber; S P Finklestein; Harris R Lieberman; Ross J Baldessarini
Increased activity and phase delay in circadian motility rhythms in geriatric depression. Preliminary observations.
Archives of general psychiatry 1988;45(10):913-7.
1988: Y Gao; R Zong; A Campbell; Nora S Kula; Ross J Baldessarini; John L Neumeyer
Synthesis and dopamine agonist and antagonist effects of (R)-(-)- and (S)-(+)-11-hydroxy-N-n-propylnoraporphine.
Journal of medicinal chemistry 1988;31(7):1392-6.
1988: Ross J Baldessarini; M Vogt
Release of 3H-dopamine and analogous monoamines from rat striatal tissue.
Cellular and molecular neurobiology 1988;8(2):205-16.
1988: P Lampen; John L Neumeyer; Ross J Baldessarini
High-performance liquid chromatographic separation and electrochemical or spectrophotometric determination of R(-)N-n-propylnorapomorphine and R(-)10,11-methylenedioxy-N-n-propylnoraporphine in primate plasma.
Journal of chromatography 1988;426(2):283-94.
1988: Martin H Teicher; N I Barber; Ross J Baldessarini; B A Shaywitz
Amphetamine accelerates and attenuates ultradian activity rhythms in preweanling rats.
Pharmacology, biochemistry, and behavior 1988;29(3):517-23.
1988: Nora S Kula; Ross J Baldessarini; F Murphy; John L Neumeyer
Substituted phenylpiperidines and phenylpyridines as reversible selective inhibitors of monoamine oxidase type A in rodent brain and liver.
Biochemical pharmacology 1988;37(4):763-6.
1988: John L Neumeyer; M Froimowitz; Ross J Baldessarini; A Campbell; Y G Gao
Neuropharmacology and stereochemistry of dopamine receptor agonist and antagonist enantiomeric pairs.
Journal of receptor research 1988;8(1-4):83-96.
1988: A Campbell; Ross J Baldessarini; M H Teicher
Decreasing sensitivity to neuroleptic agents in developing rats; evidence for a pharmacodynamic factor.
Psychopharmacology 1988;94(1):46-51.
1988: Ross J Baldessarini; B M Cohen; Martin H Teicher
Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses.
Archives of general psychiatry 1988;45(1):79-91.
1987: A Campbell; Ross J Baldessarini; Nora S Kula; V J Ram; John L Neumeyer
S(+)methylenedioxy-N-n-propylnoraporphine: an orally active inhibitor of dopamine selective for rat limbic system.
Brain research 1987;403(2):393-7.
1984: Nora S Kula; Ross J Baldessarini; A Campbell; S Finklestein; V J Ram; John L Neumeyer
Effects of N-substituted phenyltetrahydropyridines on cerebral high-affinity synaptosomal uptake of dopamine and other monoamines in several mammalian species.
Life sciences 1984;34(26):2567-75.
1982: John L Neumeyer; G W Arana; V J Ram; Nora S Kula; Ross J Baldessarini
Aporphines. 39. Synthesis, dopamine receptor binding, and pharmacological activity of (R)-(-)- and (S)-(+)-2-hydroxyapomorphine.
Journal of medicinal chemistry 1982;25(8):990-2.
1982: Ross J Baldessarini; John L Neumeyer; A Campbell; G Sperk; V J Ram; G W Arana; Nora S Kula
An orally effective, long-acting dopaminergic prodrug: (-)-10,11-methylenedioxy-N-propylnoraporphine.
European journal of pharmacology 1982;77(1):87-8.